RAGMOBI Trademark

Trademark Overview

On Thursday, December 7, 2023, a trademark application was filed for RAGMOBI with the United States Patent and Trademark Office. The USPTO has given the RAGMOBI trademark a serial number of 79388759. The federal status of this trademark filing is REGISTERED as of Tuesday, March 25, 2025. This trademark is owned by Sumitomo Pharma Co., Ltd.. The RAGMOBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the central nervous system; cells for medical use
ragmobi

General Information

Serial Number79388759
Word MarkRAGMOBI
Filing DateThursday, December 7, 2023
Status700 - REGISTERED
Status DateTuesday, March 25, 2025
Registration Number7734373
Registration DateTuesday, March 25, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the central nervous system; cells for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRACTHERA Co., Ltd.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressJP
Party NameSumitomo Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameSumitomo Pharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameSumitomo Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, February 9, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 16, 2024APPLICATION FILING RECEIPT MAILED
Monday, July 8, 2024ASSIGNED TO EXAMINER
Tuesday, July 16, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 17, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 5, 2024REFUSAL PROCESSED BY MPU
Tuesday, August 6, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, August 25, 2024REFUSAL PROCESSED BY IB
Monday, October 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 3, 2025ASSIGNED TO EXAMINER
Tuesday, January 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 25, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, June 25, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, July 3, 2025CHANGE OF OWNER RECEIVED FROM IB
Monday, July 7, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, July 7, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, July 26, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, October 4, 2025GENERIC MADRID TRANSACTION CREATED
Sunday, October 5, 2025GENERIC MADRID TRANSACTION SENT TO IB
Saturday, November 15, 2025FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

ragmobi cells medical system nervous preparations central pharmaceutical